Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jun 3;9:831541. doi: 10.3389/fmed.2022.831541

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Zhang, Zhang, Yang, Wang, Zhuo, Qin, Gong and Ai.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Changes of SBP (ΔSBP) and DBP (ΔDBP) after sacubitril-valsartan initiating in PD patients. Daily BP level was collected during 7 days before (SBP or DBP before) and after (SBP or DBP after) sacubitril-valsartan treatment. ΔSBP = [Σ(SBP after) – Σ(SBP before)]/7. ΔDBP = [Σ(DBP after) – Σ(DBP before)]/7. After treated with sacubitril-valsartan, the BP levels of PD patients were markedly decreased (light blue color). SBP, systolic blood pressure; DBP, diastolic blood pressure; PD, peritoneal dialysis.